1. Home
  2. TPST vs PXS Comparison

TPST vs PXS Comparison

Compare TPST & PXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TPST
  • PXS
  • Stock Information
  • Founded
  • TPST 2011
  • PXS 2015
  • Country
  • TPST United States
  • PXS Greece
  • Employees
  • TPST N/A
  • PXS N/A
  • Industry
  • TPST Biotechnology: Pharmaceutical Preparations
  • PXS Marine Transportation
  • Sector
  • TPST Health Care
  • PXS Consumer Discretionary
  • Exchange
  • TPST Nasdaq
  • PXS Nasdaq
  • Market Cap
  • TPST 33.0M
  • PXS 29.7M
  • IPO Year
  • TPST N/A
  • PXS N/A
  • Fundamental
  • Price
  • TPST $6.92
  • PXS $2.97
  • Analyst Decision
  • TPST Hold
  • PXS Strong Buy
  • Analyst Count
  • TPST 3
  • PXS 1
  • Target Price
  • TPST $30.00
  • PXS $10.00
  • AVG Volume (30 Days)
  • TPST 86.6K
  • PXS 53.9K
  • Earning Date
  • TPST 08-07-2025
  • PXS 08-11-2025
  • Dividend Yield
  • TPST N/A
  • PXS N/A
  • EPS Growth
  • TPST N/A
  • PXS N/A
  • EPS
  • TPST N/A
  • PXS 0.63
  • Revenue
  • TPST N/A
  • PXS $49,342,000.00
  • Revenue This Year
  • TPST N/A
  • PXS N/A
  • Revenue Next Year
  • TPST N/A
  • PXS $31.36
  • P/E Ratio
  • TPST N/A
  • PXS $4.67
  • Revenue Growth
  • TPST N/A
  • PXS 8.07
  • 52 Week Low
  • TPST $5.35
  • PXS $2.53
  • 52 Week High
  • TPST $30.03
  • PXS $5.53
  • Technical
  • Relative Strength Index (RSI)
  • TPST 46.64
  • PXS 53.18
  • Support Level
  • TPST $7.06
  • PXS $2.76
  • Resistance Level
  • TPST $7.64
  • PXS $2.93
  • Average True Range (ATR)
  • TPST 0.26
  • PXS 0.11
  • MACD
  • TPST 0.00
  • PXS 0.01
  • Stochastic Oscillator
  • TPST 22.10
  • PXS 47.13

About TPST Tempest Therapeutics Inc.

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

About PXS Pyxis Tankers Inc.

Pyxis Tankers Inc is an international maritime transportation company focused on mid-sized eco-vessels for the product tanker and dry-bulk sectors. It owns a fleet that comprises double-hull product tankers employed under a mix of short- and medium-term time charters and spot charters. The fleet owned by the company includes Konkar Ormi, Pyxis Lamda, Konkar Venture, Pyxis Karteria, and others. Each of the vessels in the fleet is capable of transporting refined petroleum products, such as naphtha, gasoline, jet fuel, kerosene, diesel, fuel oil, and other liquid bulk items, such as vegetable oils and organic chemicals. The company operates under two reportable segments, Tanker Vessels, which derive maximum revenue, and Dry-bulk Vessels.

Share on Social Networks: